RFAIU

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue —————— — Gross profit —————— — Operating expenses 105 K15 K259.66 K602.23 K390.59 K384.86 K 1.64 M Selling/general/admin expenses —————— — Research & development —————— — Operating income -213.24 K-181.73 K-229.66 K-632.23 K-360.59 K-354.86 K -1.58 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income -213.24 K-181.73 K-229.66 K-632.23 K-360.59 K-354.86 K -1.58 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 1.02 M1.08 M1.06 M213.45 K93.7 K104.43 K 1.47 M Discontinued operations —————— — Net income 1.02 M1.08 M1.06 M213.45 K93.7 K104.43 K 1.47 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.02 M1.08 M1.06 M213.45 K93.7 K104.43 K 1.47 M Basic earnings per share (Basic EPS) 0.140.140.140.060.020.02 0.24 Diluted earnings per share (Diluted EPS) 0.140.140.140.060.020.01 0.23 Average basic shares outstanding 15.01 M15.01 M15.01 M14.15 M8.34 M8.34 M — Diluted shares outstanding 15.01 M15.01 M15.01 M14.15 M8.34 M8.34 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —